Detail Information of Xenobiotics-driven Alterations in 3D Complexes
| General Information of Drug Transporter (DT) | |||||
|---|---|---|---|---|---|
| DT ID | DTD0021 Transporter Info | ||||
| Gene Name | SLC15A1 | ||||
| Transporter Name | Peptide transporter 1 | ||||
| Gene ID | |||||
| UniProt ID | |||||
| Xenobiotics-driven Alterations in 3D Complexes (XSV) of This DT | |||||
| Xenobiotic Name | Enalapril Drug Info | ||||
| Xenobiotic Type | Approved Drug | ||||
| MOA | Inhibition | ||||
| PubChem CID | 5388962 | ||||
| Docking Score | -5.723 kcal/mol | ||||
| EFMDA Details | EFMDA Info | ||||
| Xenobiotic Details | |||||
| Formula | C20H28N2O5 | ||||
| Molecular Weight | 376.4 | ||||
| Canonical SMILES |
CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N2CCC[C@H]2C(=O)O
|
||||
| InChI |
InChI=1S/C20H28N2O5/c1-3-27-20(26)16(12-11-15-8-5-4-6-9-15)21-14(2)18(23)22-13-7-10-17(22)19(24)25/h4-6,8-9,14,16-17,21H,3,7,10-13H2,1-2H3,(H,24,25)/t14-,16-,17-/m0/s1
|
||||
| InChIKey | GBXSMTUPTTWBMN-XIRDDKMYSA-N | ||||
| Pharmaceutical Properties | Xlogp | -0.1 | Rotatable Bond Count | 10 | |
| Hydrogen Bond Donor Count | 2 | Hydrogen Bond Acceptor Count | 6 | ||
| Xenobiotic Name | Cefazolin Drug Info | ||||
| Xenobiotic Type | Approved Drug | ||||
| MOA | Inhibition | ||||
| PubChem CID | 33255 | ||||
| Docking Score | -5.235 kcal/mol | ||||
| EFMDA Details | EFMDA Info | ||||
| Xenobiotic Details | |||||
| Formula | C14H14N8O4S3 | ||||
| Molecular Weight | 454.5 | ||||
| Canonical SMILES |
CC1=NN=C(S1)SCC2=C(N3[C@@H]([C@@H](C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)O
|
||||
| InChI |
InChI=1S/C14H14N8O4S3/c1-6-17-18-14(29-6)28-4-7-3-27-12-9(11(24)22(12)10(7)13(25)26)16-8(23)2-21-5-15-19-20-21/h5,9,12H,2-4H2,1H3,(H,16,23)(H,25,26)/t9-,12-/m1/s1
|
||||
| InChIKey | MLYYVTUWGNIJIB-BXKDBHETSA-N | ||||
| Pharmaceutical Properties | Xlogp | -0.4 | Rotatable Bond Count | 7 | |
| Hydrogen Bond Donor Count | 2 | Hydrogen Bond Acceptor Count | 12 | ||
| Xenobiotic Name | Dicloxacillin Drug Info | ||||
| Xenobiotic Type | Approved Drug | ||||
| MOA | Inhibition | ||||
| PubChem CID | 18381 | ||||
| Docking Score | -5.151 kcal/mol | ||||
| EFMDA Details | EFMDA Info | ||||
| Xenobiotic Details | |||||
| Formula | C19H17Cl2N3O5S | ||||
| Molecular Weight | 470.3 | ||||
| Canonical SMILES |
CC1=C(C(=NO1)C2=C(C=CC=C2Cl)Cl)C(=O)N[C@H]3[C@@H]4N(C3=O)[C@H](C(S4)(C)C)C(=O)O
|
||||
| InChI |
InChI=1S/C19H17Cl2N3O5S/c1-7-10(12(23-29-7)11-8(20)5-4-6-9(11)21)15(25)22-13-16(26)24-14(18(27)28)19(2,3)30-17(13)24/h4-6,13-14,17H,1-3H3,(H,22,25)(H,27,28)/t13-,14+,17-/m1/s1
|
||||
| InChIKey | YFAGHNZHGGCZAX-JKIFEVAISA-N | ||||
| Pharmaceutical Properties | Xlogp | 2.9 | Rotatable Bond Count | 4 | |
| Hydrogen Bond Donor Count | 2 | Hydrogen Bond Acceptor Count | 7 | ||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.